Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling

For the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1122-1124
Number of pages3
JournalCirculation
Volume134
Issue number15
DOIs
StatePublished - Oct 11 2016
Externally publishedYes

Keywords

  • anticoagulation
  • atrial fibrillation
  • renal function

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this